Ontology highlight
ABSTRACT: Purpose
We observed that the tumor microenvironment (TME) in metastatic epithelial ovarian cancer (EOC) and in other solid tumors can reprogram normal neutrophils to acquire a complement-dependent suppressor phenotype characterized by inhibition of stimulated T cell activation. This study aims to evaluate whether serum markers of neutrophil activation and complement at diagnosis of EOC would be associated with clinical outcomes.Experimental design
We conducted a two-center prospective study of patients with newly diagnosed EOC (N = 188). Blood and ascites fluid were collected at diagnosis for biomarker analysis. Patients were evaluated for progression-free survival (PFS) and overall survival (OS).Results
The median OS was 47 months (95 % CI: 34-58) and the median PF
SUBMITTER: Ricciuti J
PROVIDER: S-EPMC11871990 | biostudies-literature | 2025 Feb
REPOSITORIES: biostudies-literature